
Adaptilens
The Adaptilens A-IOL recaptures the eye’s ability to accommodate by responding to its natural signal to focus without spectacle dependence.
$18M Series A ·
Source: startupintros.com
Latest round on record: Series A, May 2026, amount undisclosed.
Total raised: $20M across 2 sourced rounds
All 3 rounds ↓Signals
Adaptilens | 2206 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com | |
| Series A | $18M | — | startupintros.com | |
| Seed | $2M | — | startupintros.com |
Timeline
- Website created
Founders and team
LC
Liane Clamen Founder & CEOsource: adaptilens.com
Companies like Adaptilens
LLNGVTY$518.5K Seed · Jul 2026
SSocteraSeed · Aug 2026
SSesame AI$250M Series B+ · Oct 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/adaptilens (get a free API key).